Mechanisms of action of intravenous immunoglobulins in autoimmune and inflammatory diseases

被引：90

作者：

Bayry, J ^{[1
]}

Misra, N ^{[1
]}

Latry, V ^{[1
]}

Prost, F ^{[1
]}

Delignat, S ^{[1
]}

Lacroix-Desmazes, S ^{[1
]}

Kazatchkine, MD ^{[1
]}

Kaveri, SV ^{[1
]}

机构：

[1] Univ Paris 06, INSERM U430, Inst Cordeliers, F-75006 Paris, France

来源：

TRANSFUSION CLINIQUE ET BIOLOGIQUE | 2003年 / 10卷 / 03期

关键词：

autoimmunity; immunomodulation; immunotherapy; idiopathic thrombocytopenic purpura; intravenous immunoglobulin;

D O I：

10.1016/S1246-7820(03)00035-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Therapeutic polyclonal intravenous immunoglobulin (IVIg) consists of normal IgG obtained from the pools of plasma of several thousand healthy blood donors. IVIg is used as substitutive treatment of primary and secondary immunodeficiences. Since the first study of Paul Imbach who demonstrated the beneficial effect in idiopathic thrombocytopenic purpura, IVIg is also used in a number of autoinumme and inflammatory diseases. The immunoregulatory effects of IVIg in autoimmune diseases depend on the interaction of Fc portion of immunoglobulins with Fc receptors and on the selection of lymphocyte repertoires of patients through variable regions of infused immunoglobulins. IVIg modulates the activation and effector functions of B and T lymphocytes, neutralizes pathogenic autoantibodies, interferes with antigen presentation and has a strong anti-inflammatory effect which depends on its interaction with the complement system, cytokines and endothelial cells. The immunomodulatory potential of IVIg in patients is thus a result of a variety of complex mechanisms that act in a synergy. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.

引用

页码：165 / 169

页数：5

共 25 条

[1] HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN EXERTS ITS BENEFICIAL EFFECT IN PATIENTS WITH DERMATOMYOSITIS BY BLOCKING ENDOMYSIAL DEPOSITION OF ACTIVATED COMPLEMENT FRAGMENTS [J].

BASTA, M ;

DALAKAS, MC .

JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (05) :1729-1735

[2] Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin [J].

Bayry, J ;

Lacroix-Desmazes, S ;

Carbonneil, C ;

Misra, N ;

Donkova, V ;

Pashov, A ;

Chevailler, A ;

Mouthon, L ;

Weill, B ;

Bruneval, P ;

Kazatchkine, MD ;

Kaveri, SV .

BLOOD, 2003, 101 (02) :758-765

[3] Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1 [J].

Bouhlal, H ;

Hocini, H ;

Quillent-Grégoire, C ;

Donkova, V ;

Rose, S ;

Amara, A ;

Longhi, R ;

Haeffner-Cavaillon, N ;

Beretta, A ;

Kaveri, SV ;

Kazatchkine, MD .

JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7606-7611

[4] TREATMENT OF REFRACTORY IMMUNE THROMBOCYTOPENIC PURPURA WITH AN ANTI-FC-GAMMA-RECEPTOR ANTIBODY [J].

CLARKSON, SB ;

BUSSEL, JB ;

KIMBERLY, RP ;

VALINSKY, JE ;

NACHMAN, RL ;

UNKELESS, JC .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (19) :1236-1239

[5] Fc receptor biology [J].

Daeron, M .

ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :203-234

[6] INFUSION OF FC-GAMMA-FRAGMENTS FOR TREATMENT OF CHILDREN WITH ACUTE IMMUNE THROMBOCYTOPENIC PURPURA [J].

DEBRE, M ;

BONNET, MC ;

FRIDMAN, WH ;

CAROSELLA, E ;

PHILIPPE, N ;

REINERT, P ;

VILMER, E ;

KAPLAN, C ;

TEILLAUD, JL ;

GRISCELLI, C .

LANCET, 1993, 342 (8877) :945-949

[7] SELECTIVE INDUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST AND INTERLEUKIN-8 IN HUMAN MONOCYTES BY NORMAL POLYSPECIFIC IGG (INTRAVENOUS IMMUNOGLOBULIN) [J].

DESOUZA, VR ;

CARRENO, MP ;

KAVERI, SV ;

LEDUR, A ;

SADEGHI, H ;

CAVAILLON, JM ;

KAZATCHKINE, MD ;

HAEFFNERCAVAILLON, N .

EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) :1267-1273

[8] NORMAL IMMUNOGLOBULIN-G (IGG) FOR THERAPEUTIC USE (INTRAVENOUS IG) CONTAIN ANTIIDIOTYPIC SPECIFICITIES AGAINST AN IMMUNODOMINANT, DISEASE-ASSOCIATED, CROSS-REACTIVE IDIOTYPE OF HUMAN ANTI THYROGLOBULIN AUTOANTIBODIES [J].

DIETRICH, G ;

KAZATCHKINE, MD .

JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) :620-625

[9] A MONOCLONAL ANTIIDIOTYPIC ANTIBODY AGAINST THE ANTIGEN-COMBINING SITE OF ANTI-FACTOR-VIII AUTOANTIBODIES DEFINES AN IDIOTOPE THAT IS RECOGNIZED BY NORMAL HUMAN POLYSPECIFIC IMMUNOGLOBULINS FOR THERAPEUTIC USE (IVIG) [J].

DIETRICH, G ;

PEREIRA, P ;

ALGIMAN, M ;

SULTAN, Y ;

KAZATCHKINE, MD .

JOURNAL OF AUTOIMMUNITY, 1990, 3 (05) :547-557

[10] TRANSIENT REVERSAL OF THROMBOCYTOPENIA IN IDIOPATHIC THROMBOCYTOPENIC PURPURA BY HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN [J].

FEHR, J ;

HOFMANN, V ;

KAPPELER, U .

NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (21) :1254-1258

← 1 2 3 →